Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies

Chagas disease is a neglected endemic disease prevalent in Latin American countries, affecting around 8 million people. The first-line treatment, benznidazole (BNZ), is effective in the acute stage of the disease but has limited efficacy in the chronic stage, possibly because current treatment regim...

Descripción completa

Detalles Bibliográficos
Autores principales: Muraca, Giuliana, Ruiz, María Esperanza, Gambaro, Rocío C, Scioli-Montoto, Sebastián, Sbaraglini, María Laura, Padula, Gisel, Cisneros, José Sebastián, Chain, Cecilia Yamil, Álvarez, Vera A, Huck-Iriart, Cristián, Castro, Guillermo R, Piñero, María Belén, Marchetto, Matias Ildebrando, Alba Soto, Catalina, Islan, Germán A, Talevi, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Beilstein-Institut 2023
Materias:
Full Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390827/
https://www.ncbi.nlm.nih.gov/pubmed/37533841
http://dx.doi.org/10.3762/bjnano.14.66

Ejemplares similares

Ejemplares similares